Fluorescence-guided resection of high-grade gliomas: A systematic review and meta-analysis

Photodiagnosis and Photodynamic Therapy

Volumn 11, Issue 4, 2014, Pages 451-458

  Su, Xing ^a   Huang, Qing Feng ^a   Chen, Hong Lin ^a   Chen, Jian ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Fluorescence guided resection; Gliomas; Meta analysis

Indexed keywords

FLUORESCEIN; FLUORESCENT DYE;

ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FLUORESCENCE; FLUORESCENCE GUIDED RESECTION; GLIOMA; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; WHITE LIGHT; BRAIN NEOPLASMS; CANCER GRADING; COMPUTER ASSISTED SURGERY; FLUORESCENCE MICROSCOPY; MORTALITY; PATHOLOGY; PREVALENCE; PROCEDURES; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TREATMENT OUTCOME;

BRAIN NEOPLASMS; FLUORESCENT DYES; GLIOMA; HUMANS; MICROSCOPY, FLUORESCENCE; NEOPLASM GRADING; PREVALENCE; RISK FACTORS; SURGERY, COMPUTER-ASSISTED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84918817462     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2014.08.001     Document Type: Article

References (36)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63(1):11-30.
2. Schwartzbaum J.A., Fisher J.L., Aldape K.D., Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2006, 2(9):494-550.
3. Stummer W., Kamp M.A. The importance of surgical resection in malignant glioma. Curr Opin Neurol 2009, 22(6):645-649.
4. Eyüpoglu I.Y., Buchfelder M., Savaskan N.E. Surgical resection of malignant gliomas-role in optimizing patient outcome. Nat Rev Neurol 2013, 9(3):141-151.
5. Sanai N., Berger M.S. Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008, 62(4):753-764. discussion 264-266.
6. Hardesty D.A., Sanai N. The value of glioma extent of resection in the modern neurosurgical era. Front Neurol 2012, 3:140.
7. Robins H.I., Lassman A.B., Khuntia D. Therapeutic advances in malignant glioma: current status and future prospects. Neuroimaging Clin N Am 2009, 19(4):647-656.
8. Babu R., Adamson D.C. Fluorescence-guided malignant glioma resections. Curr Drug Discov Technol 2012, 9(4):256-267.
9. Carapella C.M., Telera S., Oppido P.A. Surgery of malignant gliomas: advances and perspectives. Curr Opin Oncol 2011, 23(6):624-629.
10. Hebeda K.M., Saarnak A.E., Olivo M., Sterenborg H.J.C.M., Wolber J.G. 5-aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumors and in the normal brain. Acta Neurochir 1998, 140:503-513.
11. Eléouet S., Rousset N., Carré J., Bourré L., Vonarx V., Lajat Y., et al. In vitro fluorescence, toxicity and phototoxicity induced by delta-aminolevulinic acid (ALA) or ALA-esters. Photochem Photobiol 2000, 71(4):447-454.
12. Stummer W., Pichlmeier U., Meinel T., Wiestler O.D., Zanella F., Reulen H.J. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006, 7(5):392-401. ALA-Glioma Study Group.
13. Chen B., Wang H., Ge P., Zhao J., Li W., Gu H., et al. Gross total resection of glioma with the intraoperative fluorescence-guidance of fluorescein sodium. Int J Med Sci 2012, 9(8):708-714.
14. Koc K., Anik I., Cabuk B., Ceylan S. Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation. Br J Neurosurg 2008, 22(1):99-103.
15. Shinoda J., Yano H., Yoshimura S., Okumura A., Kaku Y., Iwama T., et al. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. J Neurosurg 2003, 99(3):597-603.
16. Tierney J.F., Stewart L.A., Ghersi D., Burdett S., Sydes M.R. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007, 8:16.
17. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
18. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558.
19. Moses L.E., Shapiro D., Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993, 12:1293-1316.
20. Walter S.D. Properties of the summary receiver operating characteristic (sROC) curve for diagnostic test data. Stat Med 2002, 21:1237-1256.
21. Zamora J., Abraira V., Muriel A., Khan K., Coomarasamy A. Meta-Disc: a software for meta analysis of test accuracy data. BMC Med Res Methodol 2006, 6:31-47.
22. Parmar M.K., Torri V., Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17(24):2815-2834.
23. Ritz R., Daniels R., Noell S., Feigl G.C., Schmidt V., Bornemann A., et al. Hypericin for visualization of high grade gliomas: first clinical experience. Eur J Surg Oncol 2012, 38(4):352-360.
24. Panciani P.P., Fontanella M., Schatlo B., Garbossa D., Agnoletti A., Ducati A., et al. Fluorescence and image guided resection in high grade glioma. Clin Neurol Neurosurg 2012, 114(1):37-41.
25. Valdés P.A., Kim A., Leblond F., Conde O.M., Harris B.T., Paulsen K.D., et al. Combined fluorescence and reflectance spectroscopy for in vivo quantification of cancer biomarkers in low- and high-grade glioma surgery. J Biomed Opt 2011, 16(11):116007.
26. Ewelt C., Floeth F.W., Felsberg J., Steiger H.J., Sabel M., Langen K.J., et al. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence. Clin Neurol Neurosurg 2011, 113(7):541-547.
27. Valdés P.A., Leblond F., Kim A., Harris B.T., Wilson B.C., Fan X., et al. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg 2011, 115(1):11-17.
28. Floeth F.W., Sabel M., Ewelt C., Stummer W., Felsberg J., Reifenberger G., et al. Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas. Eur J Nucl Med Mol Imaging 2011, 38(4):731-741.
29. Kremer P., Fardanesh M., Ding R., Pritsch M., Zoubaa S., Frei E. Intraoperative fluorescence staining of malignant brain tumors using 5-aminofluorescein-labeled albumin. Neurosurgery 2009, 64(Suppl. 3). ons53-61.
30. Hefti M., von Campe G., Moschopulos M., Siegner A., Looser H., Landolt H. 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institution. Swiss Med Wkly 2008, 138(11-12):180-185.
31. Swets J.A. Measuring the accuracy of diagnostic systems. Science 1988, 240:1285-1293.
32. Jones C.M., Athanasiou T. Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg 2005, 79:16-20.
33. Utsuki S., Oka H., Sato S., Shimizu S., Suzuki S., Tanizaki Y., et al. Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. Neurol Med Chir (Tokyo) 2007, 47(5):210-214.
34. Brown P.D., Maurer M.J., Rummans T.A., Pollock B.E., Ballman K.V., Sloan J.A., et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 2005, 57(3):495-504.
35. McCrea H.J., Bander E., Venn R.A., Reiner A.S., Iorgulescu J.B., Puchi L.A., et al. Gross total resection and supratentorial location significantly improve overall survival in pediatric patients with high grade glioma. Neuro-Oncology 2013, 15(1):21.
36. La Quaglia M.P., Kushner B.H., Su W., Heller G., Kramer K., Abramson S., et al. The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg 2004, 39(3):412-417.